North America Osteoarthritis Therapy Market Forecast to 2030

At 7.1% CAGR, North America Osteoarthritis Therapy Market is Speculated to be Worth US$ 13,579.80 Million by 2030, says the Research Team

According to the Research Team’ research, the North America osteoarthritis therapy market was valued at US$ 7,873.88 million in 2022 and is expected to reach US$ 13,579.80 million by 2030, registering a CAGR of 7.1% from 2022 to 2030. Rising prevalence of osteoarthritis and innovative therapy options reducing dependency on medications are among the critical factors attributed to drive the North America osteoarthritis therapy market growth.

Globally, OA affects more than 500 million people accounting 7% of the world’s population according to the CDC report. It represents a major cause of long-term disability. Additionally, osteoarthritis is also more prevalent among athletes and people who sustain joint injury or trauma. Moreover, it is more prevalent among women, accounting for 60% of global osteoarthritis cases. According to the World Health Organization (WHO) report, osteoarthritis is more prevalent among older population. Also, OA can affect anyone, but the condition is most common in adults over 40 years age. Also, The World Health Organization report further reveals that, about 73% of are living with OA are older than 55 years and 60% are female. According to the Centers for Disease Control and Prevention (CDC) report, over 32.5 million adults in the US live with OA. Thus, with the rising prevalence of OA, new therapy options such as biological therapy are gaining attention worldwide. Platelet-rich plasma (PRP) therapy is one example that has emerged as a promising treatment for patients suffering from OA. PRP enhances tissue recovery by catalyzing the body’s natural healing and tissue repair processes.

Transcutaneous Electrical Nerve Stimulation (TENS) is another example of a treatment option to treat OA. TENS helps minimize acute and chronic pains by reducing the need for medications. Therefore, rising prevalence of OA accelerates demand for innovative treatment options, reducing the dependency on medications in the coming years.

On the contrary, the product recall hampers the growth of North America osteoarthritis therapy market.

Based on therapy type, the North America osteoarthritis therapy market is segmented into transcutaneous electrical nerve stimulation (TENS), occupational therapy, physical therapy, platelet-rich plasma (PRP) therapy & stromal vascular fraction, prolotherapy, and others. The physical therapy segment held 42.1% market share in 2022, amassing US$ 3,317.33 million. It is projected to garner US$ 5,852.43 million by 2030 to register 7.4% CAGR during 2022-2030.

In terms of disease indications, the North America osteoarthritis therapy market is segmented into knee osteoarthritis, spine osteoarthritis, foot and ankle osteoarthritis, shoulder osteoarthritis, hand osteoarthritis, and others. The knee osteoarthritis segment held 51.1% share of North America osteoarthritis therapy market in 2022, amassing US$ 4,022.90 million. It is anticipated to garner US$ 7,107.49 million by 2030 to expand at 7.4% CAGR during 2022-2030.

Based on end users, the North America osteoarthritis therapy market is categorized into hospitals and clinics, specialty clinics, ambulatory surgical center, homecare, and others. The homecare segment held 31.5% share of North America osteoarthritis therapy market in 2022, amassing US$ 2,483.85 million. It is predicted to garner US$ 4,155.67 million by 2030 to expand at 6.6% CAGR between 2022 and 2030.

Based on country, the North America osteoarthritis therapy market is categorized into the US, Canada, and Mexico. Our regional analysis states that the US captured 84.9% share of North America osteoarthritis therapy market in 2022. It was assessed at US$ 6,685.71 million in 2022 and is likely to hit US$ 11,606.80 million by 2030, registering a CAGR of 7.1% during 2022-2030.

Key players operating in the North America osteoarthritis therapy market are Vision Quest Industries Inc, Dr PRP USA LLC, Zimmer Biomet Holdings Inc, DePuy Synthes Inc, Bioventus Inc, Omron Healthcare Inc, Exactech Inc, and Medi GmbH & Co KG, among others.

In March-2022, VQ OrthoCare introduced the OActive Align Osteoarthritis Knee Brace. The OActive Align offers clinicians an easy solution for custom-fitting and aligning the brace to produce exceptional patient outcomes. The brace employs a unique combination of features that precisely fit the anatomy, align the brace hinge axis, and secure it in its most effective position for corrective pain relief.

o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America osteoarthritis therapy market.
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in the North America osteoarthritis therapy market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth North America market trends and outlook coupled with the factors driving the North America osteoarthritis therapy market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.

TABLE OF CONTENTS

1. Introduction
1.1 The the Reporting Teams Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Osteoarthritis Therapy Market Landscape
4.1 Pipeline Analysis
4.1.1 Clinical Trial Pipeline Analysis
5. North America Osteoarthritis Therapy Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Prevalence of Osteoarthritis
5.1.2 Innovative Therapy Options Reducing Dependency on Medications
5.2 Market Restraints
5.2.1 Product Recall
5.3 Market Opportunities
5.3.1 Availability of Regenerative Medicine
5.4 Future Trends
5.4.1 More Effective Treatment Options
5.5 Impact of Drivers and Restraints:
6. Osteoarthritis Therapy Market – North America Market Analysis
6.1 Overview
6.1.1 Osteoarthritis Therapy Market Revenue (US$ Million), 2020-2030
7. North America Osteoarthritis Therapy Market Analysis – by Therapy Type
7.1 Overview
7.2 Transcutaneous Electrical Nerve Stimulation (TENS)
7.2.1 Overview
7.2.2 Transcutaneous Electrical Nerve Stimulation (TENS): Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
7.3 Occupational Therapy
7.3.1 Overview
7.3.2 Occupational Therapy: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Physical Therapy
7.4.1 Overview
7.4.2 Physical Therapy: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Platelet-Rich Plasma Therapy and Stromal Vascular Fraction
7.5.1 Overview
7.5.2 Platelet-Rich Plasma Therapy and Stromal Vascular Fraction: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
7.6 Prolotherapy
7.6.1 Overview
7.6.2 Prolotherapy: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
7.7 Others
7.7.1 Overview
7.7.2 Others: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
8. North America Osteoarthritis Therapy Market Analysis – by Disease Indication
8.1 Overview
8.2 Knee Osteoarthritis
8.2.1 Overview
8.2.2 Knee Osteoarthritis: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
8.3 Spine Osteoarthritis
8.3.1 Overview
8.3.2 Spine Osteoarthritis: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Foot and Ankle Osteoarthritis
8.4.1 Overview
8.4.2 Foot and Ankle Osteoarthritis: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Shoulder Osteoarthritis
8.5.1 Overview
8.5.2 Shoulder Osteoarthritis: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
8.6 Hand Osteoarthritis
8.6.1 Overview
8.6.2 Hand Osteoarthritis: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
8.7 Others
8.7.1 Overview
8.7.2 Others: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
9. North America Osteoarthritis Therapy Market Analysis – by End User
9.1 Overview
9.2 Hospitals and Clinics
9.2.1 Overview
9.2.2 Hospitals and Clinics: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
9.3 Specialty Clinics
9.3.1 Overview
9.3.2 Specialty Clinics: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Ambulatory Surgical Centers
9.4.1 Overview
9.4.2 Ambulatory Surgical Centers: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
9.5 Homecare
9.5.1 Overview
9.5.2 Homecare: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
10. North America Osteoarthritis Therapy Market – Country Analysis
10.1 North America Market Overview
10.1.1 North America: Osteoarthritis Therapy Market – Revenue and Forecast Analysis – by Country
10.1.1.1 United States: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.1.1 Overview
10.1.1.1.2 United States: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.1.3 United States: Osteoarthritis Therapy Market Breakdown, by Therapy Type
10.1.1.1.4 United States: Osteoarthritis Therapy Market Breakdown, by Disease Indication
10.1.1.1.5 United States: Osteoarthritis Therapy Market Breakdown, by End User
10.1.1.2 Canada: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.1 Overview
10.1.1.2.2 Canada: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.3 Canada: Osteoarthritis Therapy Market Breakdown, by Therapy Type
10.1.1.2.4 Canada: Osteoarthritis Therapy Market Breakdown, by Disease Indication
10.1.1.2.5 Canada: Osteoarthritis Therapy Market Breakdown, by End User
10.1.1.3 Mexico: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.1 Overview
10.1.1.3.2 Mexico: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.3 Mexico: Osteoarthritis Therapy Market Breakdown, by Therapy Type
10.1.1.3.4 Mexico: Osteoarthritis Therapy Market Breakdown, by Disease Indication
10.1.1.3.5 Mexico: Osteoarthritis Therapy Market Breakdown, by End User
11. Industry Landscape
11.1 Overview
11.2 Growth Strategies in the osteoarthritis therapy market
11.3 Organic Developments
11.3.1 Overview
11.4 Inorganic Developments
11.4.1 Overview
12. Company Profiles
12.1 Vision Quest Industries Inc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Dr PRP USA LLC
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Zimmer Biomet Holdings Inc
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 DePuy Synthes Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Bioventus Inc
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Omron Healthcare Inc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Exactech Inc
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Medi GmbH & Co KG
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
13. Appendix
13.1 About the the Reporting Teams

LIST OF TABLES

Table 1. Osteoarthritis Therapy Market Segmentation
Table 2. Ongoing Clinical Trial of Osteoarthritis
Table 3. United States: Osteoarthritis Therapy Market – Revenue and Forecast to 2030(US$ Million) – by Therapy Type
Table 4. United States: Osteoarthritis Therapy Market – Revenue and Forecast to 2030(US$ Million) – by Disease Indication
Table 5. United States: Osteoarthritis Therapy Market – Revenue and Forecast to 2030(US$ Million) – by End User
Table 6. Canada: Osteoarthritis Therapy Market – Revenue and Forecast to 2030(US$ Million) – by Therapy Type
Table 7. Canada: Osteoarthritis Therapy Market – Revenue and Forecast to 2030(US$ Million) – by Disease Indication
Table 8. Canada: Osteoarthritis Therapy Market – Revenue and Forecast to 2030(US$ Million) – by End User
Table 9. Mexico: Osteoarthritis Therapy Market – Revenue and Forecast to 2030(US$ Million) – by Therapy Type
Table 10. Mexico: Osteoarthritis Therapy Market – Revenue and Forecast to 2030(US$ Million) – by Disease Indication
Table 11. Mexico: Osteoarthritis Therapy Market – Revenue and Forecast to 2030(US$ Million) – by End User
Table 12. Organic Developments Done by Companies
Table 13. Inorganic Developments Done by Companies

LIST OF FIGURES

Figure 1. Osteoarthritis Therapy Market Segmentation, by Country
Figure 2. Osteoarthritis Therapy Market – Key Market Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Osteoarthritis Therapy Market Revenue (US$ Million), 2020-2030
Figure 5. Osteoarthritis Therapy Market Share (%) – by Therapy Type (2022 and 2030)
Figure 6. Transcutaneous Electrical Nerve Stimulation (TENS): Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
Figure 7. Occupational Therapy: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Physical Therapy: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Platelet-Rich Plasma Therapy and Stromal Vascular Fraction: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. Prolotherapy: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Others: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Osteoarthritis Therapy Market Share (%) – by Disease Indication (2022 and 2030)
Figure 13. Knee Osteoarthritis: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Spine Osteoarthritis: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Foot and Ankle Osteoarthritis: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Shoulder Osteoarthritis: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Hand Osteoarthritis: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Others: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Osteoarthritis Therapy Market Share (%) – by End User (2022 and 2030)
Figure 20. Hospitals and Clinics: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. Specialty Clinics: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. Ambulatory Surgical Centers: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
Figure 23. Homecare: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
Figure 24. Others: Osteoarthritis Therapy Market – Revenue and Forecast to 2030 (US$ Million)
Figure 25. North America: Osteoarthritis Therapy Market by Key Countries – Revenue (2022) US$ Million
Figure 26. North America: Osteoarthritis Therapy Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 27. United States: Osteoarthritis Therapy Market – Revenue and Forecast to 2030(US$ Million)
Figure 28. Canada: Osteoarthritis Therapy Market – Revenue and Forecast to 2030(US$ Million)
Figure 29. Mexico: Osteoarthritis Therapy Market – Revenue and Forecast to 2030(US$ Million)
Figure 30. Growth Strategies in the Osteoarthritis Therapy market